This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Endocrine Diseases  • Diabetes Mellitus  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Medical Ethics  • Neonatology and Infant Care  • Alert me on articles by topic

Arch Pediatr Adolesc Med. 2003;157:936.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

I thank Dr Dorman and colleagues for sharing their thoughtful project to educate families and clinicians about genetic testing for type 1 diabetes. It is important that the project will focus on families with an affected biological relative, as their "high-risk" status changes the risk-benefit of genetic testing at this time when no preventive measures exist.

I agree with Dr Dorman and colleagues that the development of decision aids will be important for the translation of scientific information on type 1 diabetes from the bench to the community. Policy guidelines must be developed to ensure that the introduction of testing, both for research and clinical purposes, minimizes risks.¹ One consideration must be the appropriate community for such testing when no therapies exist. Children are a vulnerable population; infants, more so.^2-4 Type 1 diabetes is the most common metabolic condition of childhood and, therefore, the inclusion of children in . . . [Full Text of this Article]

Lainie F. Ross, MD, PhD
University of Chicago
Department of Pediatrics
5841 S Maryland Ave, MC 6082
Chicago, IL 60637
(e-mail: lross@uchicago.edu)

RELATED ARTICLE

Need for Genetic Education for Type 1 Diabetes
, , , , , , and
Arch Pediatr Adolesc Med. ;157():935-936.
FULL TEXT